"Uremia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
| Descriptor ID |
D014511
|
| MeSH Number(s) |
C12.777.419.936 C13.351.968.419.936
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Uremia".
Below are MeSH descriptors whose meaning is more specific than "Uremia".
This graph shows the total number of publications written about "Uremia" by people in this website by year, and whether "Uremia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Uremia" by people in Profiles.
-
Binder V, Chruscicka-Smaga B, Bergum B, Jaisson S, Gillery P, Sivertsen J, Hervig T, Kaminska M, Tilvawala R, Nemmara VV, Thompson PR, Potempa J, Marti HP, Mydel P. Carbamylation of Integrin aIIb?3: The Mechanistic Link to Platelet Dysfunction in ESKD. J Am Soc Nephrol. 2022 10; 33(10):1841-1856.
-
Madero M, Cano KB, Campos I, Tao X, Maheshwari V, Brown J, Cornejo B, Handelman G, Thijssen S, Kotanko P. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor. Clin J Am Soc Nephrol. 2019 03 07; 14(3):394-402.
-
Tao X, Thijssen S, Kotanko P, Ho CH, Henrie M, Stroup E, Handelman G. Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study. Sci Rep. 2016 Mar 22; 6:23389.
-
Zou H, Zhao X, Sun N, Zhang S, Sato T, Yu H, Chen Q, Weber HP, Dard M, Yuan Q, Lanske B. Effect of chronic kidney disease on the healing of titanium implants. Bone. 2013 Oct; 56(2):410-5.
-
Kruse A, Tao X, Bhalani V, Handelman G, Levin NW, Kotanko P, Thijssen S. Clearance of p-cresol sulfate and ?-2-microglobulin from dialysate by commercially available sorbent technology. ASAIO J. 2011 May-Jun; 57(3):219-24.
-
Sarraf P, Kay J, Reginato AM. Non-crystalline and crystalline rheumatic disorders in chronic kidney disease. Curr Rheumatol Rep. 2008 Jul; 10(3):235-48.
-
Gunukula SR, Spodick DH. Pericardial disease in renal patients. Semin Nephrol. 2001 Jan; 21(1):52-6.
-
Gurwitz JH, Avorn J, Ross-Degnan D, Lipsitz LA. Nonsteroidal anti-inflammatory drug-associated azotemia in the very old. JAMA. 1990 Jul 25; 264(4):471-5.
-
Braden GL, Sanchez PG, Fitzgibbons JP, Stupak WJ, Germain MJ. Urinary doubly refractile lipid bodies in nonglomerular renal diseases. Am J Kidney Dis. 1988 Apr; 11(4):332-7.
-
Aronin N, Krieger DT. Plasma immunoreactive beta-endorphin is elevated in uraemia. Clin Endocrinol (Oxf). 1983 May; 18(5):459-64.